- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
In a May 2011 letter, Representatives Hall and Johnson ask Congressional members to join the Congressional Nanotechnology Caucus. The Caucus was formed over ten years ago and is intended to inform legislators about nanotechnology issues.
In a May 2011 letter, Representatives Ralph M. Hall (R-TX) and Eddie Bernice Johnson (D-TX) ask Congressional members to join the bipartisan and bicameral Congressional Nanotechnology Caucus. The Caucus was formed over ten years ago and is intended to inform legislators about nanotechnology issues, including the effect of nanotechnology on job creation and other economic benefits to the U.S. The National Nanotechnology Initiative (NNI), which was codified by Congress in 2003, coordinates the federal nanotechnology research and development of 25 federal agencies. Since enactment, the House has passed bills in the 110th (H.R. 5940) and 111th (H.R. 554 and H.R. 5116) Congresses to amend and reauthorize the NNI, but the Senate did not act in either Congress. Since fiscal year 2008, the NNI has received funding through annual appropriations bills. Nanotechnology stakeholders are urged to use this template letter nanotech.lawbc.com/uploads/fi
le/00076693(1).doc to let their representatives and senators know of the importance of nanotechnology issues to their constituents and urge them to participate in the Caucus.
About Bergeson & Campbell, P.C.
Bergeson & Campbell, P.C. is an AV-rated (highest ranking) Washington, D.C. law firm focusing on conventional and nanoscale, industrial, agricultural, and specialty chemical product regulation and approval matters, including TSCA matters, FIFRA/FQPA matters, FDA medical device and product approval, registration and data compensation arbitrations, chemical product litigation, and associated business counseling and litigation issues. Bergeson & Campbell's clients are involved in many businesses, including conventional and nanoscale, basic, specialty, and agricultural and antimicrobial chemicals; biotechnology, nanotechnology, and emerging transformative technologies; pharmaceuticals, medical devices, and diagnostic products; fibers; paints and coatings; printing and publishing; and plastic products.
For more information, please click here
Lynn L. Bergeson
1203 Nineteenth Street, N.W., Suite 300
Washington, District of Columbia 20036 USA
Copyright © Bergeson & Campbell, P.C.If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
FEI and University of Liverpool Announce QEMSCAN Research Initiative: University of Liverpool will utilize FEIís QEMSCAN technology to gain a better insight into oil and gas reserves & potentially change the approach to evaluating them June 22nd, 2016
French Research Team Helps Extend MRI Detection of Diseases & Lower Health-Care Costs: CEA, INSERM and G2ELab Brings Grenoble Regionís Expertise In Advanced Medicine & Magnetism Applications to H2020 IDentIFY Project June 21st, 2016